RIXIT – 100 (WFI)
Trusted Pediatric Antibiotic for Faster Recovery
RIXIT-100 WFI contains Cefixime 100 mg Oral Suspension, a broad-spectrum third-generation cephalosporin antibiotic that helps combat bacterial infections by inhibiting bacterial cell wall synthesis. It is commonly prescribed for pediatric patients suffering from respiratory tract infections, ear infections, throat infections, urinary tract infections, and other susceptible bacterial infections. Cefixime should only be used for bacterial infections and under the guidance of a qualified healthcare professional.
Composition
- Cefixime 100 mg Oral Suspension
Key Benefits
- Broad-spectrum third-generation cephalosporin antibiotic
- Effective against a wide range of susceptible bacteria
- Helps provide relief from bacterial throat, ear, and respiratory infections
- Convenient oral suspension for pediatric patients
- Pleasant-tasting formulation for better patient compliance
- IHigh-quality manufacturing by Citric Labs
Product Description
RIXIT-100 WFI by Citric Labs is a Cefixime 100 mg Oral Suspension, a third-generation cephalosporin antibiotic formulated to help treat a wide range of susceptible bacterial infections in children. Manufactured under stringent quality standards, it is an ideal choice for PCD Pharma Franchise and Third-Party Pharma Manufacturing across India.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
